Characterising the phenotypic evolution of circulating tumour cells during treatment

Download
Author
Tsao, SC-H; Wang, J; Wang, Y; Behren, A; Cebon, J; Trau, MDate
2018-04-16Source Title
Nature CommunicationsPublisher
NATURE PUBLISHING GROUPAffiliation
Medicine and RadiologySurgery (St Vincent's)
Metadata
Show full item recordDocument Type
Journal ArticleCitations
Tsao, S. C. -H., Wang, J., Wang, Y., Behren, A., Cebon, J. & Trau, M. (2018). Characterising the phenotypic evolution of circulating tumour cells during treatment. NATURE COMMUNICATIONS, 9 (1), https://doi.org/10.1038/s41467-018-03725-8.Access Status
Open AccessAbstract
Real-time monitoring of cancer cells' phenotypic evolution during therapy can provide vital tumour biology information for treatment management. Circulating tumour cell (CTC) analysis has emerged as a useful monitoring tool, but its routine usage is restricted by either limited multiplexing capability or sensitivity. Here, we demonstrate the use of antibody-conjugated and Raman reporter-coated gold nanoparticles for simultaneous labelling and monitoring of multiple CTC surface markers (named as "cell signature"), without the need for isolating individual CTCs. We observe cell heterogeneity and phenotypic changes of melanoma cell lines during molecular targeted treatment. Furthermore, we follow the CTC signature changes of 10 stage-IV melanoma patients receiving immunological or molecular targeted therapies. Our technique maps the phenotypic evolution of patient CTCs sensitively and rapidly, and shows drug-resistant clones having different CTC signatures of potential clinical value. We believe our proposed method is of general interest in the CTC relevant research and translation fields.
Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References